Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy.
about
Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Neutrophil-to-lymphocyte ratio ...... ts during tocilizumab therapy.
@en
Neutrophil-to-lymphocyte ratio ...... ts during tocilizumab therapy.
@nl
type
label
Neutrophil-to-lymphocyte ratio ...... ts during tocilizumab therapy.
@en
Neutrophil-to-lymphocyte ratio ...... ts during tocilizumab therapy.
@nl
prefLabel
Neutrophil-to-lymphocyte ratio ...... ts during tocilizumab therapy.
@en
Neutrophil-to-lymphocyte ratio ...... ts during tocilizumab therapy.
@nl
P2093
P2860
P1433
P1476
Neutrophil-to-lymphocyte ratio ...... ts during tocilizumab therapy.
@en
P2093
Chang-Keun Lee
Ohchan Kwon
Yong-Gil Kim
P2860
P304
P356
10.1080/14397595.2016.1214340
P577
2016-08-09T00:00:00Z